Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease.

Peter A Wijeratne Sara Garbarino Sarah Gregory Eileanoir B Johnson Rachael I Scahill Jane S Paulsen Sarah J Tabrizi Marco Lorenzi Daniel C Alexander

Published in: Neurology. Genetics (2021)

Our findings support the use of disease progression modeling to reveal new information from sMRI, which can potentially inform imaging marker selection for clinical trials.

Keyphrases

clinical trial
high resolution
contrast enhanced
magnetic resonance imaging
genome wide
single cell
diffusion weighted imaging
health information
phase ii
healthcare
randomized controlled trial
magnetic resonance
open label
mass spectrometry
dna methylation
photodynamic therapy